GD2 Expression in Medulloblastoma and Neuroblastoma for Personalized Immunotherapy: A Matter of SubtypeCancersDecember 8, 202210.3390/cancers14246051Cited by 22SaveCiteExport RISWatch citationsRelated PapersNo related papers foundPowered by citation graph analysis